Teva might be known for its sandals, but its new Trailwinder Hiking Shoe was great for dry land trail excursions. The post ...

Zendaya's Bold Looks Bring New Era In Fashion Actress Anjali Says Her Role ‘Parvati’ In Ram Charan's ‘Game Changer’ Is The Most Challenging Role Shahid Kapoor's Tattooed Look For Vishal Bhardwaj's ...

If you buy something, we may earn an affiliate commission. If there was a menswear equivalent of the food pyramid, men's sweatshirts would take up a significant portion. They’d occupy the second ...

A significant proportion of subjects with UC who were treated with the therapy achieved clinical remission in the study. Credit: Wasan Tita/Shutterstock. Sanofi and Teva Pharmaceuticals have reported ...

Teva and Sanofi’s duvakitug achieved remission rates up to 47.8% in trials. The drug’s efficacy surpasses that of rivals like Merck and Roche in placebo-adjusted responses. The TL1A class ...

Mr. Mahler typifies a cohort of men — often younger, yes, but also unbothered by the material’s many clichés — that have leaned into leather. There’s Shaboozey, the country-rap warbler ...

Progressive darling Rep. Alexandria Ocasio-Cortez, 35, flopped in her bid to helm the powerful House Oversight Committee, losing to Rep. Gerry Connolly, 74, who is foreshadowing political ...

Chesnot / Getty Images Teva Pharmaceuticals and Sanofi on Tuesday reported positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn's disease. The companies plan to ...

Teva Pharmaceuticals’TEVA0.63%increase; green up pointing triangle shares soared and Sanofi’sSAN-0.33%decrease; red down pointing triangle stock moved higher following positive results from ...

Meghan Markle’s latest venture may be on the back burner. After the 43-year-old and her husband, Prince Harry, 40, signed a $100 million deal with Netflix, the pair put out their latest project ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those taking placebo treatment. Teva announced it was partnering with Sanofi to ...

On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC ...